You are viewing a single comment's thread from:
RE: Proteostasis Therapeutics Inc (PTI)
Proteostasis Therapeutics Inc (NASDAQ:PTI) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday.